Company: RGBP
Filing Date: 2025-12-05
Form Type: 253G1
Source: 0001493152-25-026350
Chunk: 122

Company: Regen BioPharma Inc
Filing Date: 2025-12-05
Form: 253G1
Chunk 122
---
 embedded derivative contained in the Company’s convertible debt. The embedded derivative is carried on the balance sheet at fair value. Any unrealized change in fair value, as determined at each measurement period, is recorded as a component of the income statement and the associated carrying amount on the balance sheet is adjusted by the change.

The Company values the embedded derivative using the Black-Scholes pricing model and a derivative liability of $1,820,106 was recognized by the Company as of December 31,, 2024.

Derivative Liability consisted of the following :

|        |     | As 
 of |  December 
  31, 2024 |     | As 
 of | September 
  30, 2024 |
|:-------|:----|:---|----------:|:----|:---|----------:|
| Lender 
 1      |     | $  |   796,586 |     |    |   802,337 |
| Lender 
 4      |     | $  |   199,147 |     |    |   200,584 |
| Lender 
 5      |     | $  |   398,293 |     |    |   401,168 |
| Lender 
 6      |     | $  |   353,535 |     |    |           |
| Lender 
 7      |     | $  |    72,545 |     |    |           |
| Total  |     | $  | 1,820,106 |     | $  | 1,404,090 |

9. STOCKHOLDERS’ EQUITY

The stockholders’ equity section of the Company contains the following classes of capital stock as of December 31, 2024:

Common stock, $ 0.0001 par value; 5,800,000,000 shares authorized: 21,554,704 shares issued and outstanding.

With respect to each matter submitted to a vote of stockholders of the Corporation, each holder of Common Stock shall be entitled to cast that number of votes which is equivalent to the number of shares of Common Stock owned by such holder times one (1).

On any voluntary or involuntary liquidation, dissolution or winding up of the Corporation, the holders of the Common Stock shall receive, out of assets legally available for distribution to the Company’s stockholders, a ratable share in the assets of the Corporation.

Preferred Stock, $0.0001